Company news
Telo Genomics Corp. news in 2023
Telo Genomics Corp.'s news releases, calls and decks from 2023, newest first.
Telo Genomics Gears up for American Society of Hematology Conference
December 6, 2023
Telo Genomics Launches Physician Experience Program in the United States
November 16, 2023
Telo Genomics Advances to the Final Stage of Accreditation from The College of American Pathologists
November 7, 2023
American Society of Hematology (ASH) Accepts Validation Data from Telo Genomics for Presentation at Upcoming Annual Meeting
November 1, 2023
Telo Genomics Completes International Standards Organization ("ISO") 15189 Final Accreditation
October 26, 2023
Telo Genomics Announces Clinical Launch of Non-Invasive Cancer Diagnostic, TeloViewSMM - An Important Commercial Milestone Achieved
October 17, 2023
Telo Genomics Presents Positive Results in Assessing MRD in Multiple Myeloma Patients at the International Myeloma Society Annual Meeting
October 12, 2023
Telo Genomics Achieves Noteworthy International Standards Organization ("ISO") Regulatory Accreditation
September 6, 2023
Telo Genomics Reports Substantial Progress Toward Clinical Launch of TeloView-SMM
August 29, 2023
Telo Genomics Announces Agreement for Strategic Advisory Services
June 30, 2023
Telo Genomics Completes Oversubscribed Private Placement
June 14, 2023
Telo Genomics Presents Positive Data in Newly Diagnosed Multiple Myeloma Drug Resistance Study at EHA 2023
June 12, 2023
Telo Genomics Announces Private Placement Increased to $2,766,375 from Previously Announced Private Placement of $2,000,000
June 6, 2023
Telo Genomics Presents Superior Results of Its Smoldering Multiple Myeloma Studies at ASCO 2023
June 5, 2023
Telo Genomics Announces Private Placement of Units
May 19, 2023
Telo Genomics' Multiple Myeloma Drug Resistance Study Results Have Been Selected for Presentation at the 2023 European Hematology Congress
May 4, 2023
Telo Genomics Achieves a Major Milestone - Results of Smoldering Myeloma Study Accepted for Presentation at ASCO Annual Meeting
April 13, 2023
Telo Genomics Advances to Final Stage of Achieving ISO Certification
March 15, 2023
Telo Genomics Launches Multiple Myeloma Advisory Board at the American Society of Hematology Annual Meeting
February 22, 2023